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PROTOCOL Open Access
Adherence to prenatal iron-folic acid
supplementation in low- and middle-
income countries (LMIC): a protocol for
systematic review and meta-analysis
Mohammed Akibu1,7*†, Tesfalidet Tekelab2,3, Abdella Amano4, Merga Besho3, Stephanie Grutzmacher5,
Mesfin Tadese1 and Tesfa Dejenie Habtewold6†
Abstract
Background: Daily iron-folic acid supplementation reduces anemia and various adverse obstetric outcomes such as
preterm delivery, low birthweight, hemorrhage, and perinatal and maternal morbidity and mortality. However, its
supplementation has not been successful that attributed to several determinants including poor adherence.
Therefore, we aimed to conduct a systematic review and meta-analysis on the prevalence and determinants of
adherence to prenatal iron-folic acid supplementation in low- and middle-income countries. In addition, we will
develop a conceptual framework in the context of low- and middle-income countries (LMIC).
Methods/design: We will search PubMed, MEDLINE, EMBASE, EBSCO, Web of Science, SCOPUS, WHO Global Index
Medicus, and African Journals Online (AJOL) databases to retrieve relevant literatures. Observational (i.e., case-
control, cohort, cross-sectional, survey, and surveillance reports) and quasi-randomized and randomized controlled
trial studies conducted in LMIC will be included. The Newcastle-Ottawa Scale (NOS) and Joanna Briggs Institute (JBI)
critical appraisal checklist will be used to assess the quality of observational and randomized controlled trial studies
respectively. The pooled prevalence and odds ratio of determinants of adherence will be generated using a
weighted inverse-variance meta-analysis model. Statistical heterogeneity among studies will be assessed by
Cochran’s Q χ2 statistics and Higgins (I2 statistics) method. The result will be presented using forest plots and
Harvest plots when necessary. Furthermore, we will perform Jackknife sensitivity and subgroup analysis. Data will be
analyzed using comprehensive meta-analysis software (version 2).
Discussion: Contemporary evidence about the prevalence and determinants of adherence in LMIC will be
synthesized to generate up-to-date knowledge. To our knowledge, this is the first systematic review. It would have
substantial implications for researchers, clinicians, and policymakers for optimizing maternal and child health
outcomes in LMIC.
(Continued on next page)
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Systematic review registration: The protocol has been registered on International Prospective Register of
Systematic Review (PROSPERO), University of York Center for Reviews and Dissemination (https://www.crd.york.ac.uk/),
registration number CRD42017080245.
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Background
Anemia is a global public health problem affecting nearly
two billion people [1]. Despite vulnerability across the
population, anemia is prevalent in pregnant woman (>
40%) and young children because of increased demand
and iron-folic acid deficiency [2]. Iron-folic acid deficiency
increases the risk of blood loss during labor, maternal
mortality, preterm delivery, low birthweight, and perinatal
mortality [3, 4]. Thus, to prevent these poor health out-
comes, the World Health Organization (WHO) has rec-
ommended that all pregnant women take a standard dose
of 60 mg of elemental iron along with 400 μg of folic acid
daily for the first 6 months. Additionally, in areas where
the prevalence of anemia is over 40%, the WHO recom-
mends postpartum supplementation for 3 months [2].
A systematic review and meta-analysis of maternal
anemia in lower and middle-income countries (LMIC)
showed that 12, 19, and 18% of low birthweight, preterm
births, and perinatal mortality are associated with mater-
nal anemia respectively [5]. Accumulated body of evi-
dence shows that prenatal iron-folic acid
supplementation reduces maternal anemia and associ-
ated adverse perinatal outcomes, such as low birth-
weight, and maternal and newborn mortality [6, 7].
In LMIC, high proportion of pregnant women suffered
from anemia mainly due to poor adherence to the daily
iron-folic acid regimen [1, 8]. Furthermore, various indi-
vidual studies shows that poor adherence is common in
LMIC [9–11]. In our review, adherence is defined as tak-
ing at least five iron-folic acid tablets per week [2] or
percentage of women who consumed more than 70% of
the recommended daily dose [12].
Generally, pregnant women living in LMIC need a sup-
port for initiating and maintaining optimal adherence to
the recommended iron-folic acid supplementation [13].
Therefore, this systematic review and meta-analysis aimed
to (1) investigate the level of adherence to prenatal
iron-folic acid supplementation, (2) identify its determi-
nants, and (3) develop PRECEDE-PROCEED adherence
conceptual framework in the context of LMIC.
Methods/design
Reporting of the review findings
This protocol has been written in accordance with the
recommendation of Preferred Reporting Items for
Systematic Review and Meta-Analysis (PRISMA-P) 2015
statement [14]. The PRISMA-P Elaboration and Explan-
ation document is also used to develop the protocol [15]
(Additional file 1). The protocol has been registered on
International Prospective Register of Systematic Review
(PROSPERO), University of York Center for Reviews
and Dissemination [https://www.crd.york.ac.uk/], regis-
tration number CRD42017080245. Preferred Reporting
Items for Systematic review (PRISMA-2009) statement
will be used to report the findings. Furthermore,
PRISMA flow diagram will be used to illustrate study
screening and selection process.
PECO search guide
 P-population: pregnant mothers who have received
prenatal iron-folic acid
 E-exposure: determinants of adherence (e.g., income
level, educational status) and interventions and
intervention characteristics/components (e.g., how
the supplements are delivered to the women,
whether they receive instruction on how and why
they should take them, reminders that are sent via
text message) that are associated with prenatal iron-
folic adherence. PRECEDE-PROCEED conceptual
framework [10] will be used to select potential expo-
sures/determinants
 C-comparison: the reported reference group for
each determinant in each study (e.g., adherence in
pregnant women with high educational status versus
adherence in women with low educational status)
 O-outcome: adherence to iron-folic acid
supplementation
Data source and search strategy
PubMed, MEDLINE, EMBASE, EBSCO, Web of Science,
and SCOPUS databases will be searched to retrieve all
available studies. We will also extend our searching to
WHO Global Index Medicus and African Journals On-
line (AJOL). Cross-references of included studies will be
hand-searched as well to access additional relevant arti-
cles that may have been missed in the search. In
addition, we will search existing reviews and perform cit-
ing studies/snowballing search in PubMed and SCOPUS
databases to screen all studies that cited included
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studies. Likewise, a search for gray literature will be con-
ducted using Google Scholar and through browsing Hinari
(http://www.who.int/hinari/en/), Carolina digital reposi-
tory (https://cdr.lib.unc.edu/), and SpringerOpen-Open
repository (https://www.springeropen.com/get-published/
indexing-archiving-and-access-to-data/open-repository).
Medical subject headings (Mesh), keywords, and free-text
words were identified for selected PECO components.
“OR”, “AND”, and “NOT” Boolean operators were used to
combine search terms. Moreover, we will contact
Cochrane Pregnancy and Childbirth Group, WHO head-
quarters and regional offices, the nutrition section of the
United Nations Children’s Fund (UNICEF), the World
Food Program (WFP), and US Agency for International
Development (USAID) micronutrient program to identify
additional studies [16]. The search strategy for PubMed
database has been designed in consultation with medical
information specialist and supplemented with this proto-
col (Additional file 2). The Peer Review of Electronic
Search Strategies (PRESS) 2015 guideline statement is
followed to prepare the search strategy [17].
Eligibility criteria
The inclusion criteria are (1) observational (i.e., case-control,
cohort, cross-sectional, survey, and surveillance reports) and
quasi-randomized and randomized controlled trial studies,
(2) studies conducted in LMIC, and (3) studies that reported
the prevalence and/or least adjusted determinants of adher-
ence. The most up-to-date World Bank country classifica-
tion, when our review is published, will be used to
categorize LMIC [18]. The search will not be restricted to
any language and publication year. Qualitative studies that
thematically analyzed the determinants of adherence will be
included. Studies conducted in study populations other than
pregnant women will be excluded. Moreover, case reports
and expert opinion will be excluded. We will pilot the eligi-
bility criteria in at least 200 references and double-check if
they allow unambiguously included or excluded studies.
Selection of studies
Covidence web-based software will be used to remove
duplicated articles and carry out all of the screening pro-
cesses. First, articles will be assessed for inclusion
through a title and abstract review by two independent
reviewers. Disagreement will be solved by consensus; a
third reviewer will be invited in case of persistent
contradiction. Second, potentially eligible studies will
undergo full-text review to determine if they satisfy the
criteria set for inclusion. We will do a full-text review in
duplicates and clearly document reasons for inclusion
and exclusion. Finally, data will be extracted from all ar-
ticles that meet the inclusion criteria.
Data extraction
Data will be extracted using the Joanna Briggs Institute
(JBI) data extraction form for experimental/observational
studies (Additional file 3) [19]. The data extraction form
will be pre-tested with 3–5 eligible studies. Two reviewers
will independently extract all relevant information includ-
ing study setting, sample size, prevalence of adherence to
iron-folic acid supplementation, least-adjusted determi-
nants, and source of funding. The prevalence of adherence
to iron-folic acid will be extracted only if reported and/or
estimated based on experts’ opinion or previously pub-
lished studies or guidelines. In case of incomplete data,
the corresponding author(s) will be contacted to find full
information. Disagreement between reviewers will be re-
solved by consensus.
Quality assessment
The quality of all included studies will be rigorously assessed
by two independent reviewers. The Newcastle-Ottawa Scale
(NOS) will be used to assess the quality of cohort and
case-control articles [20]. Similarly, cross-sectional studies
will be examined using NOS adapted for cross-sectional
studies. NOS has a good inter-rater reliability and validity
[21]. The NOS criteria and its rating system have been pub-
lished elsewhere [22]. The Joanna Briggs Institute (JBI) crit-
ical appraisal checklist will be used to assess the quality of
quasi-randomized controlled trials [23].
Data synthesis and analysis
Data will be analyzed using comprehensive meta-analysis
software (version 2) [24]. Funnel plots and Egger’s regres-
sion test will be used to examine the possible risk of publi-
cation bias. Heterogeneity among studies will be assessed
by Cochran’s Q χ2 statistics and Higgins (I2 statistics)
method [25]. I2 describes the percentage of total variations
across the studies due to heterogeneity rather than chance.
I2 value greater than 80% will be indicative of considerable
heterogeneity [26]. In addition, the heterogeneity among
studies will be checked manually in terms of study popula-
tion, geographic distribution, and methods. The pooled
prevalence and odds ratio (OR) of determinants of adher-
ence will be generated using a weighted inverse-variance
meta-analysis model. If substantial heterogeneity is de-
tected, random-effects model results will be reported. Arc-
sine transformation will be carried out to minimize the
effect of studies with very high or low effect size if normal-
ity assumption will be fulfilled [27]. The result will be pre-
sented using forest plots [28] and Harvest plots [29] when
necessary. Qualitative analysis will be performed to con-
struct a PRECEDE-PROCEED conceptual framework in
the context of LMIC [10]. PRECEDE-PROCEED concep-
tual framework includes four groups of factors: predispos-
ing factors (e.g., age, educational status, income,
knowledge on anemia and prevention), enabling factors
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(e.g., number of iron/folate tablets received, acceptability
of iron/folate supplements, sides effects), reinforcing fac-
tors (e.g., number of antenatal care visits, use of reminding
techniques, support from family and relatives), and envir-
onmental factors (e.g., availability of antenatal care, access
to antenatal care) [10].
Sensitivity analysis
Leave-one-out Jackknife sensitivity analysis will be used to
stabilize the variance of studies with very low or very large
prevalence estimates [30, 31]. If the point estimate of the
new pooled effect size is outside of the 95% confidence
interval of the original/previous pooled effect size, it will
be concluded that the excluded study has a significant ef-
fect on the pooled estimate. Thus, the study should not be
included in the final analysis whether the effect of the
study is too small or too large. In addition, the random-
and fixed-effects model will be compared and decision will
be made based on the best fitting model to the data.
Subgroup analysis
Subgroup analysis will be carried out based on epidemio-
logical and/or clinical covariates that can impact estimates
such as study design, measures of adherence, age of
women, residence of women, and geographical distribution.
Potential methodological amendments
If protocol modifications are required, we will include
the detailed description of any changes along with a jus-
tification during the publication of the review results.
Discussion
The protocol has been registered and written in accord-
ance with a standardized guideline which is helpful to rep-
licate methods in other nations. Contemporary evidence
on the prevalence and determinants of adherence in
LMIC will be synthesized using an appropriate statistical
method and qualitatively using PRECEDE-PROCEED
conceptual framework [10]. Given that this is the first
study, it would have substantial implications for re-
searchers, clinicians, and policymakers in LMIC. We will
develop a conceptual framework in the context of LMIC
which could be helpful for prioritizing problems in pri-
mary healthcare and building statistical models for re-
searchers in LMIC.
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